Brentuximab vedotin consolidation post-ASCT in children with R/R HL

05.18.23

Brentuximab vedotin consolidation post-ASCT in children with R/R HL

by ASTCT Science Highlights

Multi-hit TP53MT impact on transplant outcome in myelofibrosis

05.16.23

Multi-hit TP53MT impact on transplant outcome in myelofibrosis

by ASTCT Science Highlights

Sequence variation in NKG2D, MICA, and MICB affect risk of relapse post-HCT

04.25.23

Sequence variation in NKG2D, MICA, and MICB affect risk of relapse post-HCT

by ASTCT Science Highlights

Letermovir prophylaxis against CMV after HCT

03.13.23

Letermovir prophylaxis against CMV after HCT

by ASTCT Science Highlights

Combining TIGIT inhibition with immunomodulary drugs may prevent MM progression after SCT

03.09.23

Combining TIGIT inhibition with immunomodulary drugs may prevent MM progression after SCT

by ASTCT Science Highlights

Viral-Specific T cell use in SCD patients post-HSCT

03.02.23

Viral-Specific T cell use in SCD patients post-HSCT

by ASTCT Science Highlights

T-cell immunotherapies upregulate MHC-II surface expression on AML cells

02.21.23

T-cell immunotherapies upregulate MHC-II surface expression on AML cells

by ASTCT Science Highlights

Liso-cel as second-line therapy for large B-cell lymphoma

02.14.23

Liso-cel as second-line therapy for large B-cell lymphoma

by ASTCT Science Highlights

Romiplostim impact post-auto HCT for multiple myeloma or lymphoma

02.02.23

Romiplostim impact post-auto HCT for multiple myeloma or lymphoma

by ASTCT Science Highlights

Theme picker